Terminated PHASE4 INTERVENTIONAL 2-arm NCT03936751

Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY. (CPAP-CARE)

Impact of Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: a Multicenter Randomized Controlled Study (CPAP-CARE STUDY).

Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico

Conditions Obstructive Sleep Apnea Pulmonary Edema Cardiac Cause

Interventions CPAP Nasal Strips

Updated 8 times since 2019 Last updated: Jun 6, 2024 Started: Apr 1, 2019 Primary completion: Jul 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

COVID-19 pandemic and philips cpap machine recall

Other terminated trials from Conselho Nacional de Desenvolvimento Científico e Tecnológico

See all terminations from Conselho Nacional de Desenvolvimento Científico e Tecnológico

Other Obstructive Sleep Apnea trials with similar outcome

Browse all Obstructive Sleep Apnea trials

A PHASE4 clinical study on Obstructive Sleep Apnea and Pulmonary Edema Cardiac Cause, this trial is terminated or withdrawn. The trial is conducted by Conselho Nacional de Desenvolvimento Científico e Tecnológico and has accumulated 8 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE4
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4

Status: Suspended → Terminated
Feb 2023 — Jul 2024 [monthly]

Suspended PHASE4

Status: Recruiting → Suspended
Mar 2021 — Feb 2023 [monthly]

Recruiting PHASE4

▶ Show 3 earlier versions

Jan 2021 — Mar 2021 [monthly]

Recruiting PHASE4
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE4
Jun 2019 — Feb 2020 [monthly]

Recruiting PHASE4

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado de São Paulo
Philips Respironics
University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Recife, Brazil
• São Paulo, Brazil